OrganiGram Holdings Inc. (OGI) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

OrganiGram Holdings Inc.

OGI

NASDAQ

Unprofitable

146M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 May 2025

146M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 May 2025

1.16USD

0.00 ( 0.00%)

Market Closed (as of Apr 25, 20:00 EDT)

Relative Strenght

Volume Buzz

-55%

Earning Acce

Dist 52w H.

47%

Overview Chart

Quote Panel

Updated April 27, 2025

1W 16.00 % 1M 12.62 % 3M -24.18 % 1Y -37.97 %

Key Metrics

Market Cap
146.46M
Shares Outstanding
126.26M
Share in Float
82.78M
Dividende
0

Earning Date
13 May 2025
Price Target
1.16
Average Volume
873629
Beta
1.428

Range
0.85-2.17
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.organigram.ca
Sector
Healthcare

Quote Panel

Updated April 27, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

1.22x

P/S Ratio

0.56x

P/B Ratio

0.0

Debt/Equity

-31.7%

Net Margin

$-0.3

EPS

How OGI compares to sector?

P/E Ratio

Fundamentals

Relative Strength

OGI

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

OGI

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$248M

480%

2025-Revenue

$0.22

-10%

2025-EPS

$97M

-2753%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Alliance Global Partners

upgrade

Previous: Not converted

2024-04-15

Now: Buy

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.08
vs -0.08

Q2.23

N/A

NA
vs -0.12

Q3.23

N/A

-0.04
vs NA

Q4.23

N/A

-0.14
vs NA

Q1.24

N/A

NA
vs -0.08

Q2.24

N/A

0.02
vs NA

Q3.24

N/A

-0.04
vs -0.04

Q4.24

N/A

-0.05
vs -0.14

Q1.25

N/A

-0.04
vs NA

Q2.25

N/A

-0.03
vs 0.02

Sales Growth

YoY

Current

Estimates

Q1.23

+24%

39.5M vs 31.8M

Q2.23

-14%

32.8M vs 38.1M

Q3.23

+1%

46M vs 45.5M

Q4.23

-16%

36.5M vs 43.3M

Q1.24

-5%

37.6M vs 39.5M

Q2.24

+25%

41.1M vs 32.8M

Q3.24

-3%

44.7M vs 46M

Q4.24

+17%

42.7M vs 36.5M

Q1.25

+62%

60.9M vs 37.6M

Q2.25

+64%

67.4M vs 41.1M

Return on Equity

QoQ

Q1.23

-1%

-0.01
vs 0.01

Q2.23

-71%

-0.71
vs -0.01

Q3.23

-12%

-0.12
vs -0.71

Q4.23

-6%

-0.06
vs -0.12

Q1.24

-10%

-0.10
vs -0.06

Q2.24

+1%

0.01
vs -0.10

Q3.24

-2%

-0.02
vs 0.01

Q4.24

-7%

-0.07
vs -0.02

Institutionnal Ownership

QoQ

Q1.23

114

114
vs 124

-8%

Q2.23

78
vs 114

-32%

Q3.23

73
vs 78

-6%

Q4.23

81
vs 73

11%

Q1.24

92
vs 81

14%

Q2.24

81
vs 92

-12%

Q3.24

76
vs 81

-6%

Q4.24

83
vs 76

Earnings Growth

Latest News

businesswire.com

6 hours ago

Organigram Global's Products Recognized at the CNB Awards

businesswire.com

6 hours ago

Organigram Global Shares Recording of its OG Investor Session

businesswire.com

6 hours ago

New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future

businesswire.com

6 hours ago

Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

businesswire.com

6 hours ago

Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence

businesswire.com

7 hours ago

Organigram Enters U.S. Through Acquisition of Collective Project Beverages

Company Description

1.16USD

N/A

1.22x

0.56x

0.0

-31.7%

$-0.3

$248M

$0.22

$97M

Earnings Growth

Latest News

Latest News

$248M

$0.22

$97M

Latest News

Company Description

1.16USD

N/A

1.22x

0.56x

0.0

-31.7%

$-0.3